Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Clinical trial NCT04925375 · RECRUITING
Trial details
- NCT number
- NCT04925375
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2028-07-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.